ASCO GI 2022 Conference Coverage
ASCO GI 2022 on a Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis in CheckMate 649: Nivo + Chemo vs. Chemo as 1L Treatment for Advanced GC/GEJC/EAC
By
ASCO GI 2022 Conference Coverage
FEATURING
Ryan Sugarman
By
ASCO GI 2022 Conference Coverage
FEATURING
Ryan Sugarman
Comments 0
Login to view comments.
Click here to Login
